Christopher Peetz
Director, CHIEF EXECUTIVE OFFICER · 6 filings · Latest: Jun 1, 2026
Mirum Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Jun 1, 2026 | Sale | $95.84 | 30,000 | $2.9M | 194,309 | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Jun 1, 2026 | Option Exercise | $2.94 | 30,000 | $88.1K | 224,309 | |
MIRM | CHRISTOPHER PEETZ | — | Jun 1, 2026 | Proposed Sale | $95.84 | 30,000 | $2.9M | — | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Mar 16, 2026 | Sale | $91.98 | 40,985 | $3.8M | 194,309 | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Mar 15, 2026 | Option Exercise | — | 75,000 | — | 235,294 | |
MIRM | Christopher Peetz | — | Mar 16, 2026 | Proposed Sale | $92.64 | 40,985 | $3.8M | — | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Feb 2, 2026 | Sale | $103.30 | 9,108 | $940.9K | 160,294 | |
MIRM | Christopher Peetz | — | Feb 2, 2026 | Proposed Sale | $103.80 | 9,108 | $945.4K | — | |
MIRM | Christopher Peetz | — | Jan 26, 2026 | Proposed Sale | $96.92 | 6,831 | $662.1K | — | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Jan 26, 2026 | Sale | $96.19 | 6,831 | $657.1K | 169,402 | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Jan 23, 2026 | Option Exercise | — | 12,500 | — | 176,233 | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Jan 22, 2026 | Sale | $93.33 | 7,098 | $662.4K | 163,733 | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Jan 21, 2026 | Option Exercise | — | 12,797 | — | 170,831 | |
MIRM | CHRISTOPHER PEETZ | — | Aug 11, 2025 | Proposed Sale | $62.00 | 40,000 | $2.5M | — | |
MIRM | CHRISTOPHER PEETZ | — | Aug 7, 2025 | Proposed Sale | $55.25 | 40,000 | $2.2M | — | |
MIRM | CHRISTOPHER PEETZ | — | Mar 3, 2025 | Proposed Sale | $46.91 | 40,000 | $1.9M | — |